Eric Powers to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Eric Powers has written about Platelet Aggregation Inhibitors.
Connection Strength
0.166
-
Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009 Feb; 43(2):259-67.
Score: 0.066
-
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation. 2002 May 21; 105(20):2347-54.
Score: 0.041
-
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 2001 Jun 21; 344(25):1888-94.
Score: 0.039
-
Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital. Am J Cardiol. 2012 Apr 15; 109(8):1154-9.
Score: 0.020